ATE369876T1 - Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen - Google Patents

Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen

Info

Publication number
ATE369876T1
ATE369876T1 AT95915474T AT95915474T ATE369876T1 AT E369876 T1 ATE369876 T1 AT E369876T1 AT 95915474 T AT95915474 T AT 95915474T AT 95915474 T AT95915474 T AT 95915474T AT E369876 T1 ATE369876 T1 AT E369876T1
Authority
AT
Austria
Prior art keywords
disclosed
chv
nucleotides
nucleotide
useful
Prior art date
Application number
AT95915474T
Other languages
English (en)
Inventor
Enzo Paoletti
Keith Jeffrey Limbach
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/220,151 external-priority patent/US5529780A/en
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Application granted granted Critical
Publication of ATE369876T1 publication Critical patent/ATE369876T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT95915474T 1994-03-30 1995-03-30 Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen ATE369876T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,151 US5529780A (en) 1994-03-30 1994-03-30 Nucleotide and amino acid sequences of canine herpesvirus gB and gC
US08/413,118 US5688920A (en) 1994-03-30 1995-03-29 Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor

Publications (1)

Publication Number Publication Date
ATE369876T1 true ATE369876T1 (de) 2007-09-15

Family

ID=26914613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915474T ATE369876T1 (de) 1994-03-30 1995-03-30 Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen

Country Status (10)

Country Link
US (1) US6017542A (de)
EP (1) EP0752888B1 (de)
JP (1) JP3745370B2 (de)
AT (1) ATE369876T1 (de)
AU (1) AU683557B2 (de)
CA (1) CA2182888C (de)
DE (1) DE69535561T2 (de)
DK (1) DK0752888T3 (de)
ES (1) ES2293639T3 (de)
WO (1) WO1995026751A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5753235A (en) * 1996-02-15 1998-05-19 Heska Corporation Recombinant canine herpesviruses
FR2750865B1 (fr) * 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US6761888B1 (en) 2000-05-26 2004-07-13 Neuralab Limited Passive immunization treatment of Alzheimer's disease
EP1185662B1 (de) * 1999-06-10 2011-03-02 Merial Dns-impfstoffe für hunde
MX358750B (es) * 2005-04-21 2018-08-31 Univ Florida Materiales y metodos para el control de enfermedades respiratorias en caninos.
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
EP4014989A1 (de) * 2010-08-31 2022-06-22 Boehringer Ingelheim Animal Health USA Inc. Auf das virus der newcastle-krankheit gerichtete herpesvirus-impfstoffe
CN109212205B (zh) * 2017-06-29 2021-08-20 洛阳普泰生物技术有限公司 伪狂犬病病毒gC蛋白抗体、含该抗体的试剂盒及应用
US11857622B2 (en) * 2020-06-21 2024-01-02 Pfizer Inc. Human cytomegalovirus GB polypeptide
CN116497049B (zh) * 2023-05-04 2024-03-22 江苏三仪生物工程有限公司 一种表达犬疱疹病毒gD糖基化蛋白的重组菌及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338683A (en) * 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.

Also Published As

Publication number Publication date
WO1995026751A1 (en) 1995-10-12
JP3745370B2 (ja) 2006-02-15
DK0752888T3 (da) 2007-12-03
CA2182888A1 (en) 1995-10-12
CA2182888C (en) 2007-08-07
EP0752888A1 (de) 1997-01-15
DE69535561T2 (de) 2008-06-05
AU683557B2 (en) 1997-11-13
US6017542A (en) 2000-01-25
EP0752888A4 (de) 1997-05-21
EP0752888B1 (de) 2007-08-15
AU2234495A (en) 1995-10-23
DE69535561D1 (de) 2007-09-27
JPH09511145A (ja) 1997-11-11
ES2293639T3 (es) 2008-03-16

Similar Documents

Publication Publication Date Title
Whitbeck et al. Comparison of the bovine herpesvirus 1 gI gene and the herpes simplex virus type 1 gB gene
Patel et al. A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.
ATE369876T1 (de) Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen
AU691374B2 (en) 5' to 3' exonuclease mutations of thermostable DNA polymerases
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
WO1998050554A3 (en) Enterococcus faecalis polynucleotides and polypeptides
CA2289872A1 (en) Target-dependent reactions using structure-bridging oligonucleotides
WO2000003685A3 (en) Nitrilase homologs
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
Richardson et al. Nucleotide sequence of the gene encoding the serotype-specific antigen of human (Wa) rotavirus: comparison with the homologous genes from simian SA11 and UK bovine rotaviruses
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
Dupuis et al. NADH: ubiquinone oxidoreductase from bovine mitochondria. cDNA sequence of a 19 kDa cysteine-rich subunit
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
SI9500270B (sl) Rekombinantni mersacidin in postopek za izdelavo
WO1996003506A3 (en) Analog of haemophilus hin47 with reduced protease activity
WO1997027276A3 (en) Nucleic acids encoding polypeptides having absidia lipase activity
Nanding et al. Cloning and sequence analysis of the human SNAP25 cDNA
ES8504254A1 (es) Procedimiento para obtener un polipeptido
AU4119996A (en) Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
DK0507179T3 (da) Equine herpesvira (EHV), der indeholder fremmed
ATE377087T1 (de) Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
WO2003012099A1 (fr) Synthase de chondroitine
CA2066160A1 (en) Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0752888

Country of ref document: EP

EEIH Change in the person of patent owner